The Antibody Society has partnered with numerous conference organizers, including Informa Connect, Cambridge Healthtech Institute, Hanson Wade, and Terrapinn, to ensure our members receive substantial discounts on meeting registration fees. As a courtesy, we also list meetings held by non-profit organizations, such as Gordon Research Conferences and KeyStone Symposia.
We have also partnered with Schrödinger, and are pleased to offer 20% discounts to our members for their online course, Introduction to Computational Antibody Engineering.
To access the discount codes, please log into website and navigate to the Member discount codes page in the Members Only area.
Schrödinger’s online course, Introduction to Computational Antibody Engineering, will show how industry-leading computational molecular modeling solutions are used to aid in antibody discovery and design and how to incorporate these computational approaches into your research project. This course will also provide a chance to work hands-on with Schrödinger’s BioLuminate software.
The Antibody Society members save 20% off your booking – log into the Members Only area or contact membership@antibodysociety.org for the discount code.
October 2024
The 16th annual Westin Immunogenicity Seminar will take place on October 17th 2024, in Tokyo, Japan, held by EpiVax, Inc.
The Westin Immunogenicity Seminar will take place on Thursday, October 17th, focusing on artificial intelligence (AI) and immunogenicity as applied to and impacted by new modalities and new modeling methods in biologic therapeutics discovery and development. This highly anticipated event will include a curated agenda of talks from immunology and antibody engineering experts, ample networking opportunities with the academic and industry leaders in attendance, poster presentations, and more.
The seminar will be located at the Westin Hotel in Meguro, Tokyo, and is free to attend.
Register now to save your seat!
Antibody Engineering & Therapeutics Asia Hybrid 21 – 23 October 2024 | Japan, The Westin Miyako Kyoto.
-
Bispecific and Multispecific Antibodies.
-
Clinical Antibody and ADC Programs and Lessons Learned.
-
AI-Guided Antibody Discovery & Engineering.
-
Antibody Engineering, Discovery and Selection.
-
Alternative Non-Antibody Scaffolds.
Registration fees increase each month leading up to the conference. So, the sooner you secure your spot, the more you save.
Members of The Antibody Society receive a 15% discount on the conference registration.
Contact us at membership@antibodysociety.org for the discount code!
We look forward to seeing you there! For more details, check out the event website.
Integrate Computational Biology, Generative AI & Machine Learning to Revolutionize Biologics Drug Discovery & Development.
With the transformative impact of AI-driven approaches in enhancing predictability, optimizing molecular design, and mitigating inherent risks in drug development pipelines, the CDD for Biologics summit is an indispensable platform for industry leaders to collaborate, innovate, and propel drug discovery forward amidst this era of computational excellence.
Members of The Antibody Society receive a 10% discount on conference registration for the CDD for Biologics Summit.
You can find the discount code in the members-only section under Member Discount Codes.
On October 28-29, 2024, join JAX for a two-day virtual symposium to explore how JAX’s humanized models can revolutionize your antibody-based therapeutic development. Industry experts will showcase our platforms and services, demonstrating their transformative potential at critical moments within the drug development pipeline.
The symposium includes concise, informative presentations over two days:
- Day 1: Four 15-20 minute sessions
- Day 2: Three 15-20 minute sessions
Registration is open – Don’t miss this opportunity to enhance your drug development strategy with JAX’s cutting-edge solutions!
November 2024
15th World ADC November 4 – 7, San Diego, 2024.
Antibody-drug conjugates are receiving unrivalled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and Astellas’ PADCEV, all alongside a frenzy of companies entering the field and billion-dollar partnerships and M&As from Pfizer, AbbVie, J&J, Merck, Genmab, Ipsen and beyond, ADCs have firmly positioned themselves at the forefront of oncology R&D and dealmaking.
Returning as industry’s definitive ADC forum from early discovery to late-phase manufacturing, the 15th World ADC San Diego is the world-leading, largest, and most comprehensive ADC-focused conference to maximize the therapeutic window of ADCs. Whether you have just ventured into the ADC space or are an ADC guru, you’ll leave this meeting with the insight and connections needed to overcome your challenges and make impactful strides in your work.
Gain exclusive access to the full event guide to view the full agenda with 120+ industry-leading speakers leading 6 end-to-end development content tracks:
- Discovery: Uncover cutting-edge developments in ADC payloads, linkers, and site-specific conjugation technologies to ride the tidal wave of ADC design and chemistry innovation with Heidelberg Pharma, Sutro Biopharma, and ADC Therapeutics.
- Cellular Biology: Discover novel ADC target discovery and efficiently engineer antibody properties to elevate your ADC development for novel target and therapeutic applications with Innovent Biologics, Oxford BioTherapeutics, and SOTIO Biotech.
- Translational: Evaluate ADC safety and efficacy characterization, and preclinical model selection and predictiveness to minimize the translational mismatch and supercharge successful ADC progression into the clinic with Daiichi Sankyo, AstraZeneca, and Genentech.
- Clinical: Deep-dive into brand-new early and late-stage clinical data, contextualize clinical performance, and explore ADC dose escalation to best categorize what makes a clinically effective ADC with AbbVie, Ipsen, and Mythic Therapeutics.
- Process & Analytical Development: Explore analytical characterization of ADC DAR and impurities, and learn to streamline drug-linker and conjugation process optimization to reinvigorate your ADC product quality with Mersana Therapeutics, BMS, and GlaxoSmithKline.
- Manufacturing & Supply Chain: Understand ADC manufacturing risk management and scale-up, selection criteria for CDMO partners, and regulatory CMC strategy to equip you with robust and efficient manufacturing practices under accelerated ADC development timelines with Exelixis, Merck, and Pfizer.
Access to the complete agenda here including a 8-tracked seminar day and 10 industry-beating workshops.
Don’t miss out on the chance to reunite with the antibody-drug conjugate community while reflecting on the exciting year that ADCs have had, and building momentum for the future of this innovative field.
Members of The Antibody Society receive a 10% discount on conference registration. You can find the discount code in the members-only section under Member Discount Codes.
Biologics Symposium 2024
Join the Promega team and fellow research scientists for our 8th Biologics Symposium.
Hear guest speakers discuss their latest research and innovation in biotherapeutics. Learn about new tools being developed in Promega R&D to help the development of biologic therapeutics, including monoclonal antibodies, cell therapy and gene therapy.
There will also be dedicated time for networking with fellow researchers in the biologics field. The event is free to attend.
December 2024
Antibody Engineering & Therapeutics USA 2024, December 15-18, 2024 | Marriott Marquis, San Diego
January 2025
PepTalk: The Protein Science and Production Week
January 13-16, 2025 | San Diego, CA | CHI-PepTalk.com
PepTalk: The Protein Science and Production Week is the premier conference dedicated to advancing biotherapeutic discovery and development. With over two decades of experience, PepTalk provides comprehensive programming and innovative solutions that bridge biotherapeutic research and practical application. Throughout the week, precise and dedicated pipelines offer symposia, conference tracks, and training seminars focused on protein expression, production platforms, lab automation for higher throughput, analytical methods including developability and characterization, antibody discovery and development, and new this year, targeted therapies and drug delivery systems. Learn from expert speakers, engage with a devoted community, and gain valuable tools to propel your research forward.
Experience four days of immersive learning, world-class presentations, poster sessions, keynotes, roundtable sessions, panel discussions, exhibitions, and unparalleled networking opportunities.
The Antibody Society members save 10% off the conference registration – contact membership@antibodysociety.org or visit the Members Only section of the website to find the discount code.
March 2025
NextGen BioMed 2025
Join us in London from March 12-14 at NextGen Biomed 2025 to explore the latest in biomedical research with programmes tailored to your interests.
Discover advancements in antibody discovery, transformative immunotherapy for cancer and other diseases, and the future of vaccines R&D.
Enjoy 9 content tracks, thought leadership discussions, fireside chats, workshops, and a vibrant start-up zone to form valuable connections and progress your research. We look forward to welcoming you!
Register today or explore the full event details on our website!
May 2025
Antibodies and complement : B cells, antibodies, complement functions & therapeutics: May 26-30, 2025 | Catania, Sicily, ITALY.
The antibody response and the complement system are major effector arms of the immune system. They contribute to destruction of infectious invaders and unhealthy cells. Upon Fab binding, the antibody’s Fc region induces target cell clearance by recruiting proteins of the human complement system, which trigger a sequence of reactions that results in effective phagocytosis and direct target cell lysis. Next to their beneficial role in host defenses, antibodies and complement are also involved in a plethora of pathological conditions, including autoimmunity, allergy, infections and cancer.
As the portfolio of antibody—and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.
This 4th conference on Antibodies & Complement will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts. This edition will expand to antibody-producing cell (B & plasma cell) generation and vaccine development.This is the only meeting combining antibody and complement research.Some of the critical topics to be covered include:
- Germinal Centers, B Cell And Antibody Development
- Complement Mediated Responses And Drugs
- Antibody Induced Complement Activity
- Novel Therapeutics In The Clinic
- Vaccines & Delivery Systems
View the full program, agenda, and speaker list!
